Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-25-000493
Filing Date
2025-08-13
Accepted
2025-08-13 16:08:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12485
2 AGREEMENT RE JOINT FILING stonepineex99.htm EX-99 4492
  Complete submission text file 0000935836-25-000493.txt   18858
Mailing Address 2900 NW CLEARWATER DRIVE SUITE 100-11 BEND OR 97703
Business Address 2900 NW CLEARWATER DRIVE SUITE 100-11 BEND OR 97703 541-647-5673
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Subject) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91867 | Film No.: 251211638
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)